Suppr超能文献

针对一种黑色素瘤特异性糖蛋白的单克隆抗体的制备与特性分析

Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.

作者信息

Morgan A C, Galloway D R, Reisfeld R A

出版信息

Hybridoma. 1981;1(1):27-36. doi: 10.1089/hyb.1.1981.1.27.

Abstract

An immunogen consisting of a 4M urea extract derived from human melanoma cells (M14), that was devoid of HLA-A,B,C, HLA-DR antigens and fibronectin was adsorbed to lens culinaris lectin-Sepharose 4B and used to immunize mice for production of monoclonal antibody to a melanoma-specific glycoprotein. Screening for hybridomas secreting antibodies to melanoma associated antigens was facilitated by use of a solid phase target antigen of chemically defined medium of melanoma cells (CDM). Use of these procedures allowed us to select 40 hybridomas secreting antibody which recognized determinants on melanoma cells not found on lymphoid cells. Further characterization of one of these hybridomas, 9.2.27, indicated that the antibody it secreted recognized a 240K dalton glycoprotein found on all melanoma cell lines tested but not on carcinoma, lymphoid, or fibroblastoid cultures. These results demonstrate the utility of soluble antigen preparations devoid of strongly immunogenic non tumor-specific molecules in the elicitation of tumor specific antibody. Preliminary results suggest that immunogens of this kind are superior to intact melanoma cells for production of tumor specific hybridomas.

摘要

一种免疫原,由源自人黑色素瘤细胞(M14)的4M尿素提取物组成,该提取物缺乏HLA - A、B、C、HLA - DR抗原和纤连蛋白,将其吸附到扁豆凝集素 - 琼脂糖4B上,用于免疫小鼠以产生针对黑色素瘤特异性糖蛋白的单克隆抗体。通过使用黑色素瘤细胞化学限定培养基(CDM)的固相靶抗原,促进了对分泌针对黑色素瘤相关抗原抗体的杂交瘤的筛选。使用这些程序使我们能够选择40个分泌抗体的杂交瘤,这些抗体识别在淋巴细胞上未发现的黑色素瘤细胞上的决定簇。对其中一个杂交瘤9.2.27的进一步表征表明,它分泌的抗体识别在所有测试的黑色素瘤细胞系上发现的一种240K道尔顿的糖蛋白,但在癌、淋巴或成纤维细胞培养物上未发现。这些结果证明了缺乏强免疫原性非肿瘤特异性分子的可溶性抗原制剂在引发肿瘤特异性抗体方面的效用。初步结果表明,这种免疫原在产生肿瘤特异性杂交瘤方面优于完整的黑色素瘤细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验